HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic endothelin A receptor blockade in lambs with increased pulmonary blood flow and pressure.

Abstract
Endothelin receptor blockade is an emerging therapy for pulmonary hypertension. However, hemodynamic and structural effects and potential changes in endogenous nitric oxide (NO)-cGMP and endothelin-1 signaling of chronic endothelin A receptor blockade in pulmonary hypertension secondary to congenital heart disease are unknown. Therefore, the objectives of this study were to determine hemodynamic and structural effects and potential changes in endogenous NO-cGMP and endothelin-1 signaling of chronic endothelin A receptor blockade in a lamb model of increased pulmonary blood flow following in utero placement of an aortopulmonary shunt. Immediately after spontaneous birth, shunt lambs were treated lifelong with either an endothelin A receptor antagonist (PD-156707) or placebo. At 4 wk of age, PD-156707-treated shunt lambs (n = 6) had lower pulmonary vascular resistance and right atrial pressure than placebo-treated shunt lambs (n = 8, P < 0.05). Smooth muscle thickness or arterial number per unit area was not different between the two groups. However, the number of alveolar profiles per unit area was increased in the PD-156707-treated shunt lambs (190.7 +/- 5.6 vs. 132.9 +/- 10.0, P < 0.05). Plasma endothelin-1 and cGMP levels and lung NOS activity, cGMP, eNOS, preproendothelin-1, endothelin-converting enzyme-1, endothelin A, and endothelin B receptor protein levels were similar in both groups. We conclude that chronic endothelin A receptor blockade attenuates the progression of pulmonary hypertension and augments alveolar growth in lambs with increased pulmonary blood flow.
AuthorsSohrab Fratz, Barbara Meyrick, Boaz Ovadia, Michael J Johengen, Olaf Reinhartz, Anthony Azakie, Greg Ross, Robert Fitzgerald, Peter Oishi, John Hess, Stephen M Black, Jeffrey R Fineman
JournalAmerican journal of physiology. Lung cellular and molecular physiology (Am J Physiol Lung Cell Mol Physiol) Vol. 287 Issue 3 Pg. L592-7 (Sep 2004) ISSN: 1040-0605 [Print] United States
PMID15155268 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Endothelin A Receptor Antagonists
  • Endothelin-1
  • Nitrates
  • Nitrites
  • Receptor, Endothelin A
  • Receptor, Endothelin B
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Aspartic Acid Endopeptidases
  • Metalloendopeptidases
  • Endothelin-Converting Enzymes
  • Cyclic GMP
Topics
  • Animals
  • Aspartic Acid Endopeptidases (metabolism)
  • Cyclic GMP (metabolism)
  • Endothelin A Receptor Antagonists
  • Endothelin-1 (blood, metabolism)
  • Endothelin-Converting Enzymes
  • Female
  • Hypertension, Pulmonary (physiopathology)
  • Metalloendopeptidases
  • Nitrates (metabolism)
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase (metabolism)
  • Nitrites (metabolism)
  • Pregnancy
  • Pulmonary Circulation (physiology)
  • Receptor, Endothelin A (metabolism)
  • Receptor, Endothelin B (metabolism)
  • Sheep

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: